June Industries Posts Q1 Profit of ₹0.14 Crore, Reversing Losses

CONSUMER-PRODUCTS
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
June Industries Posts Q1 Profit of ₹0.14 Crore, Reversing Losses

June Industries Ltd reported a Q1 FY27 profit of ₹0.14 crore, a significant turnaround from a prior loss. Revenue from operations was stable at ₹0.20 crore. The company focuses on trading pharmaceutical and hygiene products.

June Industries Turns Profitable in Q1 FY27

June Industries Ltd reported a net profit of ₹0.14 crore (₹14.46 lakh) for the quarter ended June 30, 2026. This marks a crucial turnaround from a net loss of ₹0.28 crore (₹27.98 lakh) in the previous quarter.

Revenue from operations for Q1 FY27 stood at ₹0.20 crore (₹20.00 lakh), showing stability compared to ₹0.20 crore (₹19.70 lakh) in Q4 FY26. Total income was ₹0.20 crore (₹20.16 lakh).

Reader Takeaway: Profitability turnaround; reliance on a single trading segment remains.

What just happened

June Industries Ltd announced its financial results for the first quarter of Fiscal Year 2027. The company achieved a Profit After Tax (PAT) of ₹0.14 crore (₹14.46 lakh), a significant improvement from the net loss of ₹0.28 crore (₹27.98 lakh) in the preceding quarter.

Basic and Diluted Earnings Per Share (EPS) for the quarter were ₹0.030.

Why this matters

The shift to profitability is a key positive for shareholders, indicating potential operational improvements or cost management successes. It suggests the company is moving in a better financial direction after a period of losses.

The backstory

In the previous quarter (Q4 FY26), June Industries had reported a net loss. The current quarter's results show a reversal of this trend.

What changes now

Investors will be looking for sustained profitability. The company's ability to maintain positive margins and manage expenses will be critical.

Risks to watch

The company operates solely within the 'Trading of pharmaceuticals, hygiene, and cleanroom products' segment. This single-segment focus presents a risk due to a lack of business diversification.

Peer comparison

No direct peer comparison is available from the filing. The company operates in the trading segment of pharmaceutical and cleanroom products.

Context metrics (time-bound)

  • Revenue from Operations (Q1 FY27): ₹0.20 crore (₹20.00 lakh)
  • Profit After Tax (Q1 FY27): ₹0.14 crore (₹14.46 lakh)
  • Previous Quarter Loss (Q4 FY26): ₹0.28 crore (₹27.98 lakh)
  • Total Expenses (Q1 FY27): ₹0.06 crore (₹5.70 lakh)

What to track next

Investors should monitor the company's ability to maintain profitability in upcoming quarters and explore potential avenues for revenue growth or diversification within its niche.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.